688193.SHG Shanghai Rendu Biotechnology Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
41.91 CNY
Close of Nov 4, 2026
39.50 62.36
Market cap
CNY 1.68B
P/E
73.5x
P/B
1.86x
ROE
2.2%
Dividend yield
0.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688193.SHG undervalued?

Graham number
Price41.91
Graham value17.00
Premium146.6%

688193.SHG trades 146.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Rendu Biotechnology Co. Ltd. A fundamental analysis

No fundamental analysis for Shanghai Rendu Biotechnology Co. Ltd. A yet.

Shanghai Rendu Biotechnology Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Rendu Biotechnology Co. Ltd. A

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of molecular diagnostic reagents products and supporting equipment in China and internationally. Its products are used in various therapeutic areas, including reproductive tract, respiratory tract, enterovirus infections, and bloodborne infectious diseases, as well as tumor auxiliary diagnosis. The company was founded in 2007 and is based in Shanghai, China.

Full company profile